Multiple Acyl-CoA Dehydrogenase Deficiency: Phenotypic and Genetic Features of a Malaysian Cohort

被引:0
|
作者
Schee, Jie Ping [1 ]
Tan, Joo San [2 ]
Tan, Cheng Yin [1 ]
Shahrizaila, Nortina [1 ]
Wong, Kum Thong [2 ,3 ]
Goh, Khean Jin [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia
[3] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Selangor, Malaysia
来源
JOURNAL OF CLINICAL NEUROLOGY | 2024年 / 20卷 / 04期
关键词
multiple acyl-CoA dehydrogenase deficiency; electron-transfer flavoprotein dehydrogenase; lipid storage myopathy; LATE-ONSET; CLINICAL-FEATURES; ETFDH MUTATIONS; RIBOFLAVIN; PATIENT; FLAVOPROTEIN; VARIANTS;
D O I
10.3988/jcn.2023.0265
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Multiple acyl-CoA dehydrogenase deficiency (MADD) is an inherited disorder of fatty acid oxidation that causes lipid storage myopathy (LSM). This is the first report on MADD that describes the phenotypic and genetic features of a Malaysian cohort. Methods Among the >2,500 patients in a local muscle biopsy database, patients with LSM were identified and their genomic DNA were extracted from muscle samples and peripheral blood. All 13 exons of the electron -transfer flavoprotein dehydrogenase gene ( ETFDH ) were subsequently sequenced. Fifty controls were included to determine the prevalence of identified mutations in the normal population. Results Fourteen (82%) of the 17 LSM patients had MADD with ETFDH mutations. Twelve (86%) were Chinese and two were Malay sisters. Other unrelated patients reported that they had no relevant family history. Nine (64%) were females. The median age at onset was 18.5 years (interquartile range=16-37 years). All 14 demonstrated proximal limb weakness, elevated serum creatine kinase levels, and myopathic changes in electromyography. Three patients experienced a metabolic crisis at their presentation. Sanger sequencing of ETFDH revealed nine different variants/mutations, one of which was novel: c.998A>G (p.Y333C) in exon 9. Notably, 12 (86%) patients, including the 2 Malay sisters, carried a common c.250G>A (p.A84T) variant, consistent with the hotspot mutation reported in southern China. All of the patients responded well to riboflavin therapy. Conclusions Most of our Malaysian cohort with LSM had late -onset, riboflavin -responsive MADD with ETFDH mutations, and they demonstrated phenotypic and genetic features similar to those of cases reported in southern China. Furthermore, we report a novel ETFDH mutation and possibly the first ever MADD patients of Malay descent.
引用
收藏
页码:422 / 430
页数:9
相关论文
共 50 条
  • [1] Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency
    Yildiz, Yilmaz
    Talim, Beril
    Haliloglu, Goknur
    Topaloglu, Haluk
    Akcoren, Zuhal
    Dursun, Ali
    Sivri, Hatice Serap
    Coskun, Turgay
    Tokatli, Aysegul
    PEDIATRIC NEUROLOGY, 2019, 99 : 69 - 75
  • [2] Cardiomyopathy in multiple Acyl-CoA dehydrogenase deficiency
    Singla, Mohit
    Guzman, Grace
    Griffin, Andrew J.
    Bharati, Saroja
    PEDIATRIC CARDIOLOGY, 2008, 29 (02) : 446 - 451
  • [3] Multiple acyl-Coa dehydrogenase deficiency: an underdiagnosed disorder in adults
    Meier, Ciselle
    Burns, Kharis
    Manolikos, Catherine
    Hodge, Samantha
    Bell, Damon A.
    INTERNAL MEDICINE JOURNAL, 2024, 54 (09) : 1567 - 1571
  • [4] Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect
    Cotelli, Maria Sofia
    Vielmi, Valentina
    Rimoldi, Marco
    Rizzetto, Manuela
    Castellotti, Barbara
    Bertasi, Valeria
    Todeschini, Alice
    Gregorelli, Valeria
    Baronchelli, Carla
    Gellera, Cinzia
    Padovani, Alessandro
    Filosto, Massimiliano
    NEUROLOGICAL SCIENCES, 2012, 33 (06) : 1383 - 1387
  • [5] Multiple acyl-COA dehydrogenase deficiency in elderly carriers
    Macchione, Francesco
    Salviati, Leonardo
    Bordugo, Andrea
    Vincenzi, Monica
    Camilot, Marta
    Teofoli, Francesca
    Pancheri, Elia
    Zordan, Roberta
    Bertolin, Cinzia
    Rossi, Silvia
    Vattemi, Gaetano
    Tonin, Paola
    JOURNAL OF NEUROLOGY, 2020, 267 (05) : 1414 - 1419
  • [6] Newborn screening and molecular features of patients with multiple acyl-CoA dehydrogenase deficiency in Quanzhou, China
    Lin, Yiming
    Zhang, Weifeng
    Chen, Zhixu
    Lin, Chunmei
    Lin, Weihua
    Fu, Qingliu
    Peng, Weilin
    Chen, Dongmei
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (05) : 649 - 652
  • [7] Multiple Acyl-CoA Dehydrogenase Deficiency: A Rare Cause of Hepatomegaly
    Nana Sede Mbakop, Raissa
    Forlemu, Arnold Nongmoh
    Manatsathit, Wuttiporn
    ACG CASE REPORTS JOURNAL, 2023, 10 (05)
  • [8] Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency
    Lin, Yiming
    Zheng, Wenwei
    Chen, Yanru
    Huang, Chenggang
    Fu, Qingliu
    Chen, Dongmei
    Peng, Weilin
    CLINICA CHIMICA ACTA, 2022, 537 : 181 - 187
  • [9] Multiple acyl-CoA dehydrogenase deficiency (MADD): A curable cause of genetic muscular lipidosis
    Maillart, E.
    Acquaviva-Bourdain, C.
    Rigal, O.
    Brivet, M.
    Jardel, C.
    Lombes, A.
    Eymard, B.
    Vianey-Saban, C.
    Laforet, P.
    REVUE NEUROLOGIQUE, 2010, 166 (03) : 289 - 294
  • [10] Multiple acyl-CoA dehydrogenase deficiency (MADD) presenting as polymyositis
    Hong, Lih En
    Phillips, Liza K.
    Fletcher, Janice
    Limaye, Vidya S.
    RHEUMATOLOGY, 2020, 59 (12) : E128 - E130